The placenta theory and the origin of infantile hemangioma.
The pathogenesis of infantile hemangioma is unknown. In recent years, much of the focus has been placed at identifying the cell type(s) responsible for tumor initiation. New discoveries in infantile hemangioma suggest an involvement of progenitor cells in the pathogenesis of this vascular tumor. Both embryonic and extra-embryonic tissues have been postulated as potential sources for these progenitor cells. This review focuses on the placental theory, which proposes that a fetal placental progenitor is the cell type of origin for infantile hemangioma. Special emphasis will be placed on placental vasculogenesis and the presence and transit of placental progenitor cells during gestation.
Barnés
Carmen M
CM
Vascular Biology Program and Department of Surgery, Children's Hospital and Harvard Medical School, Boston, MA 02115, USA. carmen.barnes@childrens.harvard.edu
Christison-Lagay
Emily A
EA
Folkman
Judah
J
D000818:Animals; D002471:Cell Transformation, Neoplastic / Q000473:pathology*; D042783:Endothelial Cells / Q000166:cytology* / Q000473:pathology; D005260:Female; D006391:Hemangioma / Q000473:pathology*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D010920:Placenta / Q000098:blood supply* / Q000166:cytology* / Q000473:pathology; D011247:Pregnancy; D013234:Stem Cells / Q000166:cytology* / Q000473:pathology